Division of Oncology
in the Department of Medicine
Welcome to the Division of Oncology, a center of excellence in patient care, medical education, and state-of-the-art research. Cancer is a major public health problem and it is also an exciting challenge for discovery and innovation.
Message from the Chief
A welcome message from the the Division of Oncology's chief, Dr. George W. Sledge Jr.
The Division of Oncology is seeking qualified faculty for several open positions. Successful applicants must hold an MD or MD/PhD degree and be board-certified or board-eligible in Medical Oncology, and have a history of significant peer-reviewed funding.
- To engage in research to create the future of cancer care
- To provide the best in care for cancer patients
- To train physicians for careers in academic medicine and research
Holbrook Kohrt (1977-2016)
It is with real sadness that we must share the news that our colleague Holbrook Kohrt died on February 24, 2016. Holbrook had been battling a serious illness all of his life, and in recent years had become resistant to standard Factor VIII therapy. He had been on investigational therapy for his disease, but became extremely ill and was transferred to Miami, where he died. Holbrook was, by everyone's estimation, one of the most brilliant translational researchers of his generation, and was poised to make great contributions to the conquest of cancer. His novel cancer immunotherapy preclinical work led directly to the development of clinical trials that may transform the care of cancer patients. His loss is a personal one for those of us who knew him, but also a real loss for cancer patients everywhere. Let us join in remembering a physician-scientist who bravely faced a life-threatening disease, never gave in, and gave his all in the service of cancer research and cancer patients. Read his story in the New York Times, March 1.
Those wishing to make contributions in Holbrook's memory may direct gifts to: Holbrook Kohrt Memorial Fellowship Fund, Medical Center Development, 3172 Porter Drive, Suite 210, Palo Alto, CA 94304
Faculty Spotlight - Sigurdis Haraldsdottir, MD
Sigurdis Haraldsdottir, MD (assistant professor, Hematology/Oncology), is a recent (October 2015) newcomer to the Department of Medicine faculty. She is a native of Iceland, a fact that colors her professional interests as well as the ways she chooses to spend her free time.
Please join me in welcoming Dr. Manali Patel to our faculty. Manali will be an Assistant Professor (MCL) with a focus on Health Services Research. Manali received a B.A. from the University of North Carolina, where she also received a Master’s degree in public health and her medical degree. She moved to Stanford in 2006, where she did both her residency as well as her Hematology-Oncology Fellowship. Subsequently she received a KL2 training award, pursued an Outcomes Research fellowship, and completed a Maste'rs in Health Services Research. She has been an Instructor in our division since 2013, and has served on the staff of the Palo Alto VA Hospital. We are delighted to have her join our ranks.
We are also pleased to welcome Dr. Tyler Johnson to the faculty as Assistant Professor in the CE line, as a member of our Gastrointestinal Oncology group. Many of you know Tyler from his years here at Stanford, first as a resident (including his tenure as Chief Resident for the Department) and then subsequently as a fellow in our program. A graduate (Magna Cum Laude) of Brigham Young University, Tyler received his medical degree from the University of Pennsylvania. Both prior to coming to Stanford, and during his training here, Tyler has been active as a teacher, and he will continue this in his new role.